Product Information
XELJANZ XR 11 MG TABLET is a brand product labeled by Pfizer Inc., priced at $207.8483 per EA under NDC 00069050130. Its NADAC has been published 506 times since Oct 19, 2016.
Strength
11 mg/1
Manufacturer
Pfizer Inc.NDC
00069050130
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOFACITINIB CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA208246On Market Since
3/7/2016
Pharmacological Classes
Price Statistics
The NADAC for XELJANZ XR 11 MG TABLET has been published 506 times since Oct 19, 2016, and over the history we have for it it has risen 87.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $207.8483 per EA |
|---|---|
| All-time high | $207.8483 (Jun 24, 2026) |
| All-time low | $110.8257 (Oct 19, 2016) |
| 52-week high | $207.8483 |
| 52-week low | $196.8559 |
| Median price | $159.8195 |
| Average price | $161.5176 |
| Largest weekly change | +9.4% (Jan 4, 2017) |
| Weeks tracked | 506 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tofacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XELJANZ XR 11 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XELJANZ XR 11 MG TABLET, manufactured by Pfizer Inc., is $207.8483 per EA (NDC 00069050130), effective Jun 24, 2026.
How has the price of XELJANZ XR 11 MG TABLET changed over time?
Over the history we have for it, the NADAC for XELJANZ XR 11 MG TABLET has risen 87.5%. It has been tracked across 506 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for XELJANZ XR 11 MG TABLET?
Since Oct 19, 2016, the NADAC for XELJANZ XR 11 MG TABLET has ranged from a low of $110.8257 (Oct 19, 2016) to a high of $207.8483 (Jun 24, 2026), with a median of $159.8195 per EA.
Are there cheaper alternatives to XELJANZ XR 11 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XELJANZ XR 11 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures XELJANZ XR 11 MG TABLET?
XELJANZ XR 11 MG TABLET (NDC 00069050130) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification